Asthma Management: New Developments
Clicking the "View this Article" button will open the issue as a resizable PDF. To take the test for
the issue, return to this Introduction page and click the "Take the Test" button. The Introduction
page will remain open after you open this issue.
You may need to re-size or close the issue in order
to see the Introduction page.
Asthma is a chronic inflammatory disease that affects over
339 million individuals worldwide. Characterized by variable
airflow limitation and bronchial hyperresponsiveness, symptoms
include wheezing, shortness of breath, chest tightness, and/or
cough. Asthma symptoms are episodic in nature, often worse
at night or in the early morning, and can be triggered by factors
such as exercise, airborne allergens, pollution, cigarette smoking,
weather changes (eg, very cold, low humidity), and viral upper
respiratory infections. To diagnose asthma, patients must have
a history of variable respiratory symptoms, as well as limited
expiratory airflow that has been confirmed with spirometry.
The long-term goals of asthma management are to achieve
good symptom control that enables patients to maintain normal
activity levels, to minimize persistent airflow limitation, side
effects from treatment, and asthma-related exacerbations, and to
prevent asthma-related death...
Publication Date: 02/22/2020
Expiration Date: 02/22/2023
CE Credit: 1.5 (0.15 CEU)
Type of Activity: Knowledge-based
This program was developed by The Rx Consultant and published by Continuing Education Network, Inc.
The Rx Consultant accepts no advertising or financial support from the pharmaceutical industry and
is funded solely by the purchase of programs. The Rx Consultant is dedicated to providing unbiased,
balanced information to health care practitioners.
Programs developed by The Rx Consultant are written by health care providers with expertise in the topic
area, peer-reviewed, extensively edited, and fact-checked. This development process was created to insure
that every program presents information that is current, accurate, relevant to "real world" health care
providers, and written in an easy reading, "plain English" style.
Jessica Wallace, PharmD, BCPS is an Assistant Professor
of Pharmacy Practice at Lipscomb University College
of Pharmacy and Health Sciences in Nashville, TN. She
maintains a practice site precepting students and residents
on the Internal Medicine Service at the Veterans Affairs
Tennessee Valley Healthcare System, Nashville.
Jonathan Hughes, PharmD, BCPS, BCACP is an
Ambulatory Care Clinical Pharmacist Specialist at the Saint
Louise Family Medicine Center in Murfreesboro, TN. He is
also an Assistant Professor for the University of Tennessee
Health Science Center, holding joint appointments with the
Department of Clinical Pharmacy, College of Pharmacy, and
the Department of Clinical Medical Education, College of
Dr. Wallace and Dr. Hughes report no financial relationship with the manufacturer(s) or provider(s) of any commercial product(s) or
service(s) that appear in this issue.
This accredited program is targeted to
Goals & Objectives
At the conclusion of this program, participants will be able to:
- Discuss the current GINA recommendations for stepwise treatment of asthma, including the role for SABA, LABA, and
inhaled corticosteroids (ICS). Recognize ICS-LABA combination products approved for the treatment of asthma and
their age-specific daily doses.
- Discuss the reasons and possible solutions for poor asthma medication adherence. Provide 2 examples of personalized
controller therapy that may not be consistent with general treatment recommendations in clinical practice guidelines.
- Describe the rationale for the use of biologics in patients with severe asthma uncontrolled by ICS and bronchodilator
therapy. List approved agents, dosing, and potentially serious side effects.
The Rx Consultant is a publication of Continuing Education Network, Inc.
Continuing Education Network, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education as a
provider of continuing pharmacy education.
Continuing Education Network is approved by the California Board of Registered Nursing, Provider Number CEP 13118. Programs approved by CA BRN are accepted by most State Boards of Nursing.
ACPE Universal Activity Number: 0428-0000-20-002-H01-P
Exam & Credit Statement Procedures
Upon successful completion of this program and the post test (70%), 1.5 hours of continuing education credit will be awarded. To receive credit and your exam score, please complete the exam questions and
Editorial and Review Board
Chief Editor and CE Administrator
Terry M. Baker, PharmD
Tracy Farnen, PharmD
James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Coordinator
Associate Clinical Professor
School of Pharmacy
University of California San Francisco
San Francisco, CA
Richard Ron Finley, B.S. Pharm.,R.Ph.
Clinical Pharmacist (volunteer faculty)
University of California, San Francisco (UCSF) Memory and Aging Center
Lecturer (Emeritus) UCSF, Department of Clinical Pharmacy
Health Sciences Clinical Professor, UCSF School of Pharmacy
San Francisco, CA
Ray Dolby Brain Health Center, Sutter Health/CPMC
San Francisco, CA
Consult Pharmacist Aging and Adult Health Services
San Francisco Health Department
San Francisco, CA
Julio R. Lopez, PharmD, FCSHP
Chief of Pharmacy Service
VA Northern California Health Care System
Adjunct Clinical Professor
College of Pharmacy
Assistant Clinical Professor
School of Pharmacy
University of California, San Francisco
San Francisco, CA Adjunct Professor
Thomas J. Long School of Pharmacy
University of the Pacific
Visiting Associate Professor and Lecturer
Samuel Merritt University
Pamela Mausner, MD
Helen Berlie, Pharm.D. CDE, BCACP
Clinical Assistant Professor, Pharmacy Practice
Wayne State University
Ambulatory Care Specialist - Diabetes
Health Centers Detroit Medical Group
Senior Editorial Advisor
Gerard Hatheway, PharmD, PhD
Belinda M. Danielson, RPh
Christopher M. DeSoto, PharmD
Angie S. Graham, PharmD
Cynthia Chan Huang, PharmD, MBA
Fred Plageman, PharmD
Editorial Advisor and Clinical Practice Consultant for Nurse Practitioners
Meuleman, RN, C, MS
About the Rx Consultant
The Rx Consultant is a monthly publication dedicated to providing health care professionals with the information they need to
educate patients about drugs and manage drug therapy. The reader is responsible for confirming
the information presented here and interpreting it in relation to each patient's specific situation before utilizing the information.
Any hardware that supports Microsoft Windows, Apple Mac OS, iOS, or Android, and meets the software requirements.
Browser that supports TLS 1.1 + and PDF files.
This includes Microsoft Internet Explorer 11, Google Chrome 38, Google Android OS 5.0 Browser, Apple Safari (version 7 for desktop, 5 for mobile), Mozilla Firefox 27, newer versions of these browsers, as well as some earlier versions that may require additional configuration.
Adobe Acrobat Reader is recommended, and is required for some browsers.
Note: TLS 1.1 and 1.2 support is required for browser security. Click here for TLS browser support details.
Required. Broadband recommended. (T1, DSL, Cable, G4 or higher.)